CoChat

Retinoic acid and cancer treatment

Open access

The DOI matches its Crossref record; 87 of the 87 references it cites were found in a registry or an index.

Abstract

Retinoic acid which belongs to the retinoid class of chemical compounds is an important metabolite of vitamin A in diets. It is currently understood that retinoic acid plays important roles in cell development and differentiation as well as cancer treatment. Lung, prostate, breast, ovarian, bladder, oral, and skin cancers have been demonstrated to be suppressed by retinoic acid. Our results also show that low doses and high doses of retinoic acid may respectively cause cell cycle arrest and apoptosis of cancer cells. Also, the common cell cycle inhibiting protein, p27, and the new cell cycle regulator, Cdk5, are involved in retinoic acid's effects. These results provide new evidence indicating that the molecular mechanisms of/in retinoic acid may control cancer cells' fates. Since high doses of retinoic acid may lead to cytotoxicity, it is probably best utilized as a potential supplement in one's daily diet to prevent or suppress cancer progression. In this review, we have collected numerous references demonstrating the findings of retinoic acid in melanoma, hepatoma, lung cancer, breast cancer, and prostate cancer. We hope these observations will shed light on the future investigation of retinoic acid in cancer prevention and therapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.7603/s40681-014-0022-1

Cites

87 of 87 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 87 references

Research works printed but not linked: 1

  1. Terao M, Fratelli M, Kurosaki M, Zanetti A, Guarnaccia V, Paroni G, et al. Induction of miR-21 by retinoic acid in estrogen receptorpositive breast carcinoma cells: biological correlates and molecular targets. J Biol Chem 2011; 286: 4027–42. · DOI

Cited by

See all 109

Metadata

Authors
Chen, M.-C., Hsu, S.-L., Lin, H., & Yang, T.-Y.
Affiliations
  • Taichung Veterans General Hospital (TW)
  • National Chung Hsing University (TW)
Corresponding author
  • Lin, Ho
  • Yang, Tsung-Ying
Venue
BioMedicine
Published
2014-11-28
Volume
4
Issue
4
Pages
22-22
ISSN
  • 2211-8020 (ISSN-L)
  • 2211-8039
OpenAlex
W2139840459
Cited by
105
References
86
Citations by year
2026: 2 · 2025: 7 · 2024: 9 · 2023: 10 · 2022: 9 · 2021: 13 · 2020: 14 · 2019: 16 · 2018: 6 · 2017: 13 · 2016: 5 · 2015: 1
FWCI
2.60
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Biomedicine (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
National Science Council
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
  • Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
Keywords
retinoic acid, retinoids, vitamin A metabolites, chemoprevention, cancer therapy, cell cycle arrest, apoptosis, p27, cyclin-dependent kinase 5, melanoma, hepatocellular carcinoma, lung cancer, breast cancer, prostate cancer, dietary supplementation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Retinoic acid and cancer treatment. https://app.cochat.ai/papers/10.7603/s40681-014-0022-1
The paper
Chen, M.-C., Hsu, S.-L., Lin, H., & Yang, T.-Y. (2014). Retinoic acid and cancer treatment. BioMedicine. https://doi.org/10.7603/s40681-014-0022-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.